Sign in to view content

Percentage of Patients Maintained on Quarterly Anti-VEGF Dosing for the Treatment of Neovascular Age-Related Macular Degeneration Across Key Clinical Trials

David A. Eichenbaum, MD, FASRS

Video
Published 2018

Related

Episode 201: AMD Drug Updates with Dr. Allen Ho, including Gene Therapy
Jayanth Sridhar, MD
Member Podcasts
2019
Effect on Treatment Burden Post - Versus Pre-Iluvien Based on Prior DME Treatments
Caesar K. Luo, MD, FASRS
Annual Meeting Talks
2018
A Novel Biocompatible Film to Promote Retinals Breaks Repair and Macular Hole Closure
Stanislao Rizzo, MD
Annual Meeting Talks
2018

Category: Age-Related Macular Degeneration

See more